Anaplastic Oligodendroglioma
What's New
Last Posted: Mar 07, 2023
- Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma.
Rosenberg Shai, et al. The oncologist 2018 0 (12) 1500-1510 - Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi Toshihiko, et al. Brain tumor pathology 2018 0 (2) 71-80 - Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.
Ruiz María Fernanda, et al. Molecular and clinical oncology 2021 0 (2) 150 - The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas.
Pareira Eriel Sandika, et al. Brain tumor pathology 2022 0 (2) 79-87 - Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
Möllemann Maria, et al. International journal of cancer 2004 0 (3) 379-85 - Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomas.
Watanabe T, et al. Acta neuropathologica 2001 0 (3) 185-9 - Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
Ueki Keisuke, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2002 0 (1) 196-201 - Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
Makino Yasuhide, et al. BMC cancer 2021 9 (1) 1025 - Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.
Dono Antonio et al. Journal of neuro-oncology 2020 Oct - Genetic landscape of extreme responders with anaplastic oligodendroglioma.
Holdhoff Matthias, et al. Oncotarget 2017 5 (22) 35523-35531
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: